Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 October 2025 | Story Anthony Mthembu | Photo Supplied
Prof Liezel Lues
Prof Liezel Lues, the newly elected President of the International Association of Schools and Institutes of Administration (IASIA).

Prof Liezel Lues, Professor in the Department of Public Administration and Management at the University of the Free State (UFS), has been elected as the President of the International Association of Schools and Institutes of Administration (IASIA)

The election took place on 14 October 2025 in Mexico City during the IASIA Board of Management meeting, where Prof Lues received an overwhelming 22 out of 25 votes. Describing her appointment as the pinnacle of her public service career, she reflected.

“It is a moment where hard work, dedication, and unwavering focus have truly converged, and I am deeply grateful to all those who have supported my growth and opened doors along the way.”   

Prof Lues, whose term will run until 2028, was nominated by former IASIA President Dr Najat Zarrouk and endorsed by Prof Ing. Juraj Nemec, Chairperson of the International Commission on Accreditation of Public Administration (ICAPA). 

 

Leading global collaboration in public administration 

As IASIA President, Prof Lues will provide leadership and strategic direction for the association's affairs, overseeing 127 international organisations across 56 countries. Her responsibilities include appointing - subject to the approval of the incoming Board of Management - seven Vice-Presidents representing each global region: Africa, Latin America and the Caribbean, the Middle East, Asia, Europe, North America, and Australia. 

In addition to these duties, she will be travelling extensively to strengthen global partnerships and advance IASIA’s mission of promoting excellence in public administration education and practice. 

 

A vision for a forward-looking IASIA

Prof Lues shared that her motivation to accept this leadership role stems from a desire to contribute strategically to global collaboration and research - particularly in empowering women in academia and public service.

“As a woman in academia and leadership, I was motivated by the need to model representation and inspire others to step into leadership spaces traditionally dominated by men,’’ she explained.  

Looking ahead, she envisions steering IASIA towards a more agile, forward-looking institution. Her priorities for the next three years include: 

  • Promoting and maintaining a collegial and collaborative organisational culture;
  • Embracing digital transformation and innovation;
  • Fostering cross-disciplinary, impactful research; and
  • Investing in sustainable institutional development and rehabilitation strategies. 

Drawing from her extensive experience - first in government and later in academia - Prof Lues expressed confidence in her ability to lead the association into a new era.  

“I am confident that my vision will build on the association's previous successes and elevate it to new horizons in the coming terms,” she said. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept